Abstract
A Namalwa cell line, KJM-1, which was adapted to serum-free medium is thought to be a good host cell line for recombinant DNA technology. We previously reported the expression of human β-interferon (β-IFN) in Namalwa KJM-1 (Miyaji, 1989a). The utility of Namalwa KJM-1 for expression of foreign genes was further examined. As a target gene to be expressed, human lymphotoxin (hLT) cDNA was used. It was engineered for expression in Namalwa KJM-1 using a simian virus 40 (SV40)-based expression vector pAGE107 (Miyaji, 1989a). It contains all components necessary for the expression of cDNA in mammalian cells. The expression vector was introduced into Namalwa KJM-1 by electroporation. Among the transformants, clone 7 was further examined for the expression of hLT in serum-free medium. The production level of hLT was augmented with the increase of the cell density. Thus it was further indicated that Namalwa KJM-1 is useful for production of foreign gene products.
Similar content being viewed by others
Abbreviations
- HEPES:
-
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
References
Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV and Harkins RN (1985) Human tumor necrosis factor. J. Biol. Chem. 260: 2345–2354.
Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S and Cerami A (1986) Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83: 1670–1674.
Dorai H and Moore GP (1987) The effect of dihydrofolate reductase-mediated gene amplification on the expression of transfected immunoglobulin genes. J. Immunol. 139: 4232–4241.
Gray PW, Aggarwal BB, Benton CV, Bringman TS, Henzel WJ, Jarrett JA, Leung DW, Moffat B, Ng P, Svedersky LP, Palladino MA and Nedwin GE (1984) Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature 312: 721–724.
Hosoi S, Mioh H, Anzai C, Sato S and Fujiyoshi N (1988) Establishment of Namalva cell lines which grow continuously in glutamine-free medium. Cytotechnology 1: 151–158.
Miyaji H, Mizukami T, Hosoi S, Sato S, Fujiyoshi N and Itoh S (1989a) Expression of human β-interferon in Namalwa cells which were adapted to serum-free medium. Cytotechnology in press.
Miyaji H, Nishi T and Itoh S (1989b) Expression of human lymphotoxin derivatives in Escherichia coli and comparison of their biological activity in vitro. Agric. Biol. Chem. 53: 277–279.
Nishi T, Saito A, Oka T, Itoh S, Takaoka C and Taniguchi T (1984) Construction of plasmid expression vectors carrying the Escherichia coli tryptophan promoter. Agric. Biol. Chem. 48: 669–675.
Paul NL and Ruddle NH (1988) Lymphotoxin. Ann. Rev. Immunol. 6: 407–438.
Sato S, Kawamura K and Fujiyoshi N (1983) Animal cell cultivation for production of biological substances with a novel perfusion culture apparatus. J. Tissue Culture Methods 8: 167–171.
Shaw G and Kamen R (1986) A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659–667.
Weidle UH and Buckel P (1987) Establishment of stable mouse myeloma cells constitutively secreting human tissue-type plasminogen activator. Gene 57: 131–141.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miyaji, H., Harada, N., Mizukami, T. et al. Expression of human lymphotoxin in Namalwa KJM-1 cells adapted to serum-free medium. Cytotechnology 4, 39–43 (1990). https://doi.org/10.1007/BF00148809
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00148809